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Background: Previous experimental investigations have suggested that guaraná (Paullinia cupana Kunth, supplied
by EMBRAPA Oriental) consumption is associated with a lower prevalence of cardiovascular metabolic diseases and
has positive effects on lipid metabolism, mainly related to low density lipoprotein (LDL) levels. As LDL oxidation is
an important initial event in the development of atherosclerosis, we performed in vitro and in vivo studies to
observe the potential effects of guaraná on LDL and serum oxidation.
Methods: The in vivo protocol was performed using blood samples from 42 healthy elderly subjects who habitually
ingested guaraná (GI) or never ingested guaraná (NG). The formation of conjugated dienes (CDs) was analyzed from
serum samples. The in vitro protocols were performed using LDL obtained from 3 healthy, non-fasted,
normolipidemic voluntary donors who did not habitually ingest guaraná in their diets. The LDL samples were
exposed to 5 different guaraná concentrations (0.05, 0.1, 0.5, 1, and 5 μg/mL).
Results: GI subjects demonstrated lower LDL oxidation than did NG subjects (reduction of 27%, p < 0.0014),
independent of other variables. In the GI group the total polyphenols was positively associated with LDL levels.
Also, guaraná demonstrated a high antioxidant activity in vitro, mainly at concentrations of 1 and 5 μg/mL,
demonstrated by suppression of CDs and TBARS productions, tryptophan destruction and high TRAP activity.
Conclusions: Guaraná, similar to other foods rich in caffeine and catechins such as green tea, has some effect on
LDL oxidation that could partially explain the protective effects of this food in cardiometabolic diseases.
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Foods rich in catechins and caffeine, such as tea and cof-
fee, are the most popular beverages in the world, and
have been consumed for thousands of years because of
their alluring flavors and health benefits. Several epidemio-
logical and experimental investigations have described an
inverse association between tea consumption and cardio-
vascular diseases [1]. A recent study described an associ-
ation between coffee and tea consumption and a low
morbidity and mortality risk from stroke, coronary heart
disease (CHD), and all causes of mortality in 37,514* Correspondence: felix@ufsm.br
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reproduction in any medium, provided the orsubjects followed for 13 years [2]. A possible causal factor
associated with tea and coffee consumption is the role of
bioactive compounds present in these foods in metabolic
pathways related to body weight loss, and a consequent
reduction of the overall risk for developing metabolic
syndrome [3].
However, it is important to analyze whether other
foods rich in these compounds show biological proper-
ties similar to those of the guaraná used in energy drinks
(Paullinia cupana H.B.K., Sapindaceae) [4]. Guaraná is a
rainforest vine that was domesticated in the Amazon for
its caffeine-rich fruits. During the last two decades, gua-
raná has emerged as a key ingredient in various ‘sports’
and energy drinks [5]. Energy drinks have increased in
popularity with adolescents and young adults. Caffeine,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Parameters from people who habitually ingest
guaraná (GI) and those who never ingest guaraná (NG)
Variables GI NG p
Means ± SD Means ± SD
Age (years) 73.6 ± 6.5 75.2 ± 9.4 0.56
BMI (Kg/m2) 27.4 ± 3.3 27.0 ± 4.2 0.58
Waist circumference (cm) 87.6 ± 11.1 82.5 ± 10.9 0.14
SBP (mmHg) 126.1 ± 15.9 130.0 ± 15.8 0.44
DBP (mmHg) 73.51 ± 8.3 76.51 ± 4.9 0.19
Glucose (mg/dL) 103.7 ± 12.8 108.6 ± 14.1 0.21
Cholesterol total (mg/dL) 189.7 ± 30.8 230.2 ± 61.6 0.009
Triglycerides (mg/dL) 128.7 ± 47.7 150.9 ± 51.7 0.57
LDL (mg/dL) 132.5 ± 45.8 161.1 ± 52.6 0.08
HDL (mg/dL) 42.6 ± 24.0 42.2 ± 19.1 0.96
Uric acid (mg/dL) 4.2 ± 1.9 5.4 ± 2.9 0.16
TBARS 21.7 ± 7.9 19.9 ± 7.0 0.44
Protein carbonilation 0.17 ± 0.09 0.14 ± 0.07 0.25
Total polyphenols 2.7 ± 0.8 2.7 ± 0.5 0.98
SD = standard deviation; BMI = Body mass index (Kg/m2); SBP = systolic blood
pressure; DBP = diastolic blood pressure. Comparison between GI and NG
elderly subjects performed by t-student test. p value = statistical significance.
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is generally considered safe by the US Food and Drug
Administration (FDA), although adverse effects can occur
at varying amounts. Guaraná, which contains caffeine in
addition to small amounts of theobromine, theophylline,
and tannins, is also recognized as safe by the FDA [6]. Be-
cause the consumption of guaraná is growing in many
countries, studies on its functional properties are needed.
Previous experimental investigations have suggested
that guaraná has positive effects on lipid metabolism [7],
in body weight loss [8], and increases basal energy expend-
iture [9]. Furthermore, studies suggested that guaraná
exhibits a cardioprotective effect by inhibiting platelet ag-
gregation [10]. These all positive effects contributed to re-
duce the risk factors for cardiovascular diseases. However,
in contrast to green tea and coffee, on which many epi-
demiological studies have been performed, investigations
involving guaraná consumption are difficult to perform be-
cause guaraná originates in a specific Brazilian Amazonian
region (Maués-AM) [5]. Besides, there is no information
whether guaraná consumption might increase the resis-
tance to low density lipoprotein (LDL) oxidation.
For this reason, a controlled study was recently per-
formed to analyze the association between habitual gua-
raná consumption and the prevalence of metabolic disease
(obesity, hypertension, type 2 diabetes, and dyslipidemia)
in an elderly population living in the Amazon’s Riverine
region (Maués-AM). The study observed a lower preva-
lence of hypertension, obesity, and metabolic syndrome in
the subjects which self-reported habitual guaraná con-
sumption (GI) than in subjects who reported never ingest-
ing guaraná (NG). Additionally an association was found
between habitual guaraná consumption and lower choles-
terol (total and LDL) and advanced oxidative protein
product (AOPP) levels [11]. The potential effect of gua-
raná on LDL levels as well as oxidative biomarkers
(AOPP) could provide a possible causal explanation for
the lower prevalence of some cardiovascular metabolic
diseases observed in Maués’s study.
These results lead us to verify whether guaraná may
have a possible antiatherogenic activity. Lipid peroxida-
tion induced by free radicals has been implicated in the
pathogenesis of various diseases. Numerous in vitro and
animal studies have shown that oxidative modification of
LDL is an important initial event for the development of
atherosclerosis [12]. Moreover, it is known that age is
one of the major risk factor for atherosclerotic vascular
disease [13]. Plasma cholesterol, triglyceride, LDL, poly-
unsaturated fatty acid (PUFA), total fatty acid and mal-
ondialdehyde levels, were found to increase in aged
humans compared with young groups [14]. In addition,
VLDL + LDL oxidizability increased and total thiol con-
tent levels in plasma decreased in aged humans and rats
compared with young groups [14].The experimental studies described earlier and the
established inverse relationship between the consump-
tion of fruit and vegetables and cardiovascular diseases
have led to a number of new studies on patients and
populations that, for the most part, seem to reinforce
the central role of antioxidants as protective nutrients
[13]. Considering these facts, we performed an in vivo
study to investigate the potential effects of guaraná in
elderly people on serum oxidation and an in vitro study
in order to investigate the antioxidant effects of guaraná
on the LDL and serum oxidation.
Results
Baseline characteristics of subjects
The baseline characteristics of GI and NG elderly sub-
jects included in the in vivo serum oxidation assay are
presented in Table 1. In general, the two elderly groups
were similar in BMI, blood pressure, glucose levels, and
certain lipid parameters. However, the levels of total
cholesterol were higher in the NG subjects than in the
GI subjects. Additionally, the oxidative biomarker para-
meters such as TBARS, total polyphenols, and protein
carbonylation were similar for the two groups.
Conjugated diene levels in Maués’s population
The serum samples from elderly GI and NG subjects
were evaluated for maximum CD production. The diene
levels were significantly different between the two groups
analyzed here. The GI group showed lower diene forma-
tion (reduction of 27%, p < 0.0014) than the NG group
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tion in GI and NG groups was also analyzed. Figure 1B
shows that both men (reduction of 21%, p < 0.0168) and
women (reduction of 33%, p < 0.0311) who drank guaraná
showed a significant decrease in maximum CD production
















































Figure 1 Maximum conjugated dienes production in serum
from Maués inhabitants. Serum (diluted 100-fold) in PBS 10 mM
(pH7.4) was incubated at 37°C for 180 min in the presence of 30 μM
CuSO4. Conjugated diene formation was measured by determining
the absorbance at 245 nm every 20 min. In panel A, maximum CD
production in serum of GI and NG subjects. In panel B, gender effect
on maximum CD production between GI and NG groups. NG (white
bars) and GI (gray bars). In panel C, the t(1/2) indicates the time
required to achieve 50% CD production.
* p < 0.05 compared to white bar.drink guaraná. Figure 1C shows the time required to
achieve 50% CD production during CuSO4-induced serum
oxidation. This result shows no significant difference be-
tween NG and GI groups. Pearson correlation tests were
performed and there are no significant correlations be-
tween maximum conjugated dienes and either total choles-
terol (r = 0.188, p = 0.23) or LDL levels (r = 0.137, p = 0.39).
However, we found a significant correlation between
total polyphenols and LDL levels in the GI group (r = 0.643,
p = 0.007) but not in the NG group (r = 0.197, p = 0.563).
In vitro guaraná effect on LDL oxidation
Conjugated diene (CD) production
Isolated LDL samples incubated with different concen-
trations of guaraná showed a concentration-dependent
increase in the lag phase of LDL oxidation (r2 = 0.88,
p < 0.001). Guaraná concentrations in the range of 0.5 –
5 μg/mL significantly inhibited CuSO4-induced LDL oxi-
dation, increasing the lag phase (Figure 2A). At concentra-
tions of 1 and 5 μg/mL, guaraná totally prevented LDL
oxidation during an assay time of 180 min (Figure 2B).
However, guaraná had no effect on the maximum rate of
oxidation (data not shown).
TBARS production
LDL oxidation was also evaluated by TBARS formation.
Figure 3 shows a significant effect of guaraná in prevent-
ing TBARS formation induced by CuSO4. The protective
effect of guaraná was similar to that demonstrated in the
CD experiments. Guaraná at 1 μg/mL showed a signifi-
cant effect during an assay time of 60 – 180 minutes. At
a concentration of 5 μg/mL, guaraná prevented TBARS
formation during an assay time of 60 – 360 min.
LDL tryptophan fluorescence
Figure 4 shows the time required to achieve 50% Trp
fluorescence (t1/2) during CuSO4-induced LDL oxidation.
When compared to the control group, the presence of
guaraná at all concentrations tested significantly increased
the t1/2 of Trp. Guaraná at 1 and 5 μg/mL showed a total
protection during 180 minutes. This result was similar
that for the conjugated dienes and TBARS formation.
CD production in serum
Serum oxidation was determined by CD formation at
245 nm. No oxidation occurred in serum when the medium
did not contain CuSO4. Figure 5 shows that guaraná at con-
centrations of 1 and 5 μg/mL was able to cause a significant
increase in the lag phase of oxidation. At the highest con-
centration, guaraná totally inhibited the serum oxidation
during the assay time. Similar to its effect on LDL oxida-
tion, guaraná demonstrated no effect on the maximum oxi-
dation rate in serum oxidation (data not shown).
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Figure 2 Effects of guaraná on LDL oxidation. LDL (50 μg
protein/mL) was incubated in PBS 10 mM (pH 7.4) at 37°C in the
presence of CuSO4 5 μM. Conjugated diene formation was
measured by determining the absorbance at 234 nm every 20 min. In
panel A, incubation medium did not contain guaraná (1) or contained
0.05 μg/mL (2), 0.1 μg/mL (3), 0.5 μg/mL (4), 1 μg/mL (5) or 5 μg/mL
(6) of guaraná and control without CuSO4 and guaraná (C). In panel B,
the value of the lag phase determined graphically by the intercept of
the tangents to the slow and fast increase of the diene absorption.
Experiments were repeated six times, showing similar results. * p < 0.05
compared to group without CuSO4 and guaraná. † p < 0.05 compared
to group with CuSO4 and without guaraná.















Figure 3 Effects of guaraná on thiobarbituric acid reactive
substances (TBARS) production during CuSO4-induced LDL
oxidation. LDL (50 μg protein/mL) was incubated in PBS 10 mM
(pH 7.4) at 37°C in the presence of CuSO4 5 μM. Incubation medium
did not contain guaraná and CuSO4 (1) or contained CuSO4 (2),
0.01 μg/mL (3), 0.05 μg/mL (4), 0.1 μg/mL (5), 1 μg/mL (6) or 5 μg/mL
of guaraná. Experiments were repeated three times.
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Figure 6 shows the antioxidant potential of guaraná
when AAPH was used as pro-oxidant. This method is
based on the use of a water-soluble azo compound, AAPH
[2,20-azo-bis(2-amidinopropane)-dihydrochloride], as a re-
liable and quantifiable source of alkyl peroxyl radicals. The
thermal decomposition of these compounds in the pres-
ence of luminol produces luminescence, which is quenched
by the addition of peroxyl radical scavengers [15]. Guaraná
concentrations ranging from 0.01 to 10 μg/mL were used
in this experiment. We observed that all concentrations
tested were able to reduce the AAPH-induced luminol oxi-
dation, and that guaraná concentrations of 0.5 – 10 μg/mL
demonstrated very strong inhibition.Discussion
To our knowledge, this is the first study conducted to
investigate the potential association between guaraná ef-
fect on LDL and serum oxidation. The results showed
that guaraná ingestion (GI) resulted in lower maximum
conjugated diene production than that found in an el-
derly NG group (Figure 1). Furthermore, in vitro assays
showed that guaraná increased the lag phase in the oxi-
dation of LDL and serum in vitro (Figures 2 and 5), and
also prevented TBARS production (Figure 3) and Trp
destruction (Figure 4) in LDL oxidation. Moreover, we
observed that guaraná extract demonstrates a peroxyl
radical scavenger activity (Figure 6).
The effects of guaraná on LDL and serum oxidation
are probably associated with some bioactive compounds
(catechins and xantines) that are similar to those found
in other foods, such as green tea [4]. Tea polyphenols
are well studied and there are numerous studies consis-
tently describing these compounds as having antioxidative,
antithrombogenic, antiinflammatory, hypotensive, hypocho-
lesterolemic, antihypertensive, and antiobesogenic effects
[16]. The potential beneficial effects of daily guaraná con-
sumption described by Krewer et al [11] include a lower
prevalence of hypertension, obesity, and metabolic syn-
drome, and lower cholesterol (total and LDL) and AOPP
levels in GI subjects. These effects are similar to those
described in epidemiological studies involving green tea
[17]. We believe that the results depicted here concerning
the LDL oxidation could contribute in the elucidation of
potential causal factors related to these associations.
First, it is important to consider the bioactive effects
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Figure 4 Effect of guaraná on Trp destruction in CuSO4-induced LDL oxidation. LDL (50 μg protein/mL) was incubated in PBS with 5 μM
CuSO4 with different guaraná concentrations. Fluorescence (Ex/Em = 282/331 nm) was measured at intervals of 20 min at 37°C. The t(1/2) means
the time required for reaching half Trp fluorescence. Experiments were repeated three times, showing similar results. * p < 0.05 compared to
control with copper and without guaraná (black bar).
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to methylxanthines, such as caffeine, theobromine, and
theophylline, and also to tannins, saponins, catechins,
epicatechins, proanthocyanidols, as well as trace concen-
trations of many other compounds [18]. Effect of caf-
feine on LDL resistance to oxidative modification has
been excluded by several in vitro [19] and ex vivo [20]
studies. Indeed, we tested the TRAP activity of caffeine
and theobromine and we observed no effect for these
two compounds (data not shown). On the other hand,
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Figure 5 Effects of guaraná concentrations on phase lag of
conjugated dienes formation during serum oxidation. Serum
(diluted 100-fold) in PBS 10 mM (pH7.4) was incubated at 37°C for
180 min in the presence of 30 μM CuSO4. Conjugated diene
formation was measured by determining the absorbance at 245 nm
every 20 min. Experiments were repeated three times, showing
similar results. * p < 0.05 compared to control with copper and
without guaraná (black bar).decreased body weight in some clinical studies [21]. These
effects of caffeine may contribute to prevent the other risk
factors related to atherosclerotic vascular disease such as
waist circumference and blood pressure [11].
It has been shown that guaraná inhibits the lipid per-
oxidation process, an effect apparently associated with
the high tannin content of the seeds, which reach con-
centrations between 16% and 31% [22,23]. Fresh tea leaf














Figure 6 In vitro effect of guaraná on total radical-trapping
antioxidant potential (TRAP). The reaction mixture contained
10 mM AAPH, 35 μM luminol and guaraná at different
concentrations dissolved in 0.1 M glycine buffer (pH 8.6). The
luminescence was measured every 5 minutes during 5 hours. The
area under curve (AUC) was evaluated. (V) Vehicle and (C) Control.
The bars represent mean ± S.D. of five different experiments. * p <
0.001 compared to control and vehicle group. There is no difference
between vehicle and control group.
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the dry leaf weight and there is no tannic acid in tea
[24]. Tannins are polyphenolic compounds having mo-
lecular masses between 500 and 3000 Da and a sufficiently
large number of phenolic groups [25]. Yamaguti-Sasaki
et al. [22] identified some procyanidins (condensed tan-
nins) as epicatechin-(4β→ 8)-epicatechin (procyanidin
B2), catechin-(4α→ 8)-catechin (procyanidin B3), and cat-
echin-(4α→ 8)-epicatechin (procyanidin B4). It has been
demonstrated that green tea catechins demonstrate anti-
oxidant activity by scavenging free radicals and chelating
redox active transition-metal ions [26]. Catechins have
many phenolic hydroxyl groups in their structures and
have been shown to inhibit oxidative modification of LDL
when added before initiation of oxidation [27]. However,
the mechanisms by which these flavonoids inhibit LDL
oxidation have not been clarified. Because of their amphi-
pathic nature, flavonoids may act within the LDL particle
in a manner similar to that of vitamin E, or may act in a
manner comparable with that of ascorbic acid in the extra-
particle environment of LDL. Considering our in vivo
results (Figure 1) and the significant correlation between
the total polyphenols and the LDL levels in the GI group,
we may suppose that polyphenols from guaraná could in-
corporate into LDL, turning the serum from GI subjects
less susceptible to oxidation in vitro.
Guaraná’s effect on lipid peroxidation in vitro is in
agreement with Mattei et al [23], who showed that gua-
raná extract inhibited lipoperoxidation even at low con-
centrations (1.2 μg/mL). Besides their in vitro effects,
catechins demonstrate additional effects in vivo by inhi-
biting redox active transcriptional factors, inhibiting
pro-oxidant enzymes, and inducing antioxidant enzymes,
which could explain their beneficial effects in vivo [26].
These effects make the potential use of guaraná extract
even most promising to promote protection against
atherogenesis.
In our in vivo study, the diene levels were significantly
lower in GI than in NG subjects. It may indicate that
guaraná intake is able to provide an additional antioxi-
dant protection to serum and, mainly, to LDL. It was in
agree with our in vitro data, which could increase the
lag phase of serum and LDL oxidation, prevent TBARS
production and tryptophan destruction (Figures 2, 3, 4
and 5). However, the time required to achieve 50% CD
production was not significant different. We believe that
it was not significant because of the low number of
subjects. In the actual in vivo condition, the polyphenols
and methylxanthines in plasma may work together
to prevent LDL oxidation. These polyphenols may be
more easily incorporated into LDL in vivo than in vitro.
Although guaraná polyphenols may be metabolized
quickly after entering the circulation, it is possible that
these metabolites also exert preventive effects on LDLoxidation. Repeated exposure of LDL particles to gua-
raná polyphenols over a long period of time may enrich
the LDL particles sufficiently to make them less suscep-
tible to oxidative stress.
It is important to ponder some considerations asso-
ciated with the methodological design of our in vivo
protocol. Since the in vivo study was performed using a
group of elderly subjects, and without controlling for the
amounts of guaraná ingested or the ingestion of other
foods rich in antioxidants or bioactive compounds, it is
important to conduct additional controlled studies on
the possible effect of guaraná ingestion on LDL oxida-
tion levels to confirm the results described here.
Conclusion
In summary, in vivo results showed that guaraná intake
could reduce the diene levels in serum from elderly sub-
ject. This positive effect of guaraná could be confirmed
by in vitro results which showed an increased resistance
to LDL oxidation. It was due to high content of poly-
phenolic compounds, which may act to prevent athero-
genesis through a combination of effects, including the
other positive effects of guaraná on lipid metabolism [7],
in body weight loss [8], and increases basal energy ex-
penditure [9], besides the lower prevalence of hyperten-
sion, metabolic syndrome, and lower cholesterol and
AOPP levels in GI subjects [11]. Considering these
results, our study indicates that consumption of guaraná
regularly or its possible inclusion in diet-based therapies
could yield certain health benefits and potential defense
against oxidative stress and metabolic disorders.
Materials and methods
In vivo assay: effect of habitual guaraná consumption on
serum oxidation
The elderly patients were classified into two groups
based on self-reported data: those who habitually in-
gested guaraná (at least 5 times a week; GI) and those
who never ingested guaraná (NG). From a previous data
and biological bank of the study performed by Krewer et al
[11] that investigated elderly included in GI (n = 421) and
NG groups (NG, n = 239) we select 42 samples from 22
males and 20 females (≥ 60 years of age, 23 GI and 19 NG)
to perform a serum oxidation analysis. We selected sub-
jects without previous life style as smoking habit and
higher alcoholic beverage consumption and without mor-
bidities that could to influence the analysis of serum oxida-
tion as: type 2 diabetes mellitus, obesity, dyslipidemia,
severe hypertension, metabolic syndrome, cardiovascular
diseases, neoplasias and other metabolic diseases. The
methodology used to determine biochemical parameters
from elderly Riverine inhabitants who habitually ingest
guaraná (GI) and those who never ingest guaraná (NG) are
described in materials and methods from Krewer et al [11].
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the Ethical Committee of the Universidade do Estado do
Amazonas, Brasil (nº 807/04). Since the vast majority of
the elderly included in this study were illiterate, oral
consent or fingerprint in Term was obtained to indicate
their voluntary participation in the study after the
researchers read the consent form to the patients.
Venous blood was drawn from these 42 previous
selected elderly subjects into tubes containing no anti-
coagulant and centrifuged at 1000 g for 15 min and the
serum was stored at −20°C until to be analyzed. Serum
diluted 100-fold was incubated at 37°C in a medium
containing 10 mM phosphate buffer (pH 7.4). The oxida-
tion was initiated by the addition of CuSO4 (30 μM, final
concentration) and conjugated dienes (CD) formation was
monitored at 245 nm as previously described [28].
Guaraná extract
Powdered Paullinia cupana Kunth seed produced and
supplied by EMBRAPA Oriental (Agropecuary Research
Brazillian Enterprise) located Western Amazon in Maués,
Amazonas-Brazil was used in all experiments. The guaraná
powder was conserved in dry conditions at ± 4°C, pro-
tected against light action until the extracts preparations.
We used a hydro-alcoholic extract of Paullinia cupana
Kunth using alcohol and water (70:30) to 100 mL of ex-
traction fluid prepared at a concentration of 300 mg/mL.
The detailed description and determination of mainly
bioactive compounds presents guaraná extract used in
this study is presented in Bittencourt et al (Bittencourt
LS, Machado DC, Machado MM, Santos GFF, Algarve
TD, Marinowic DR, Ribeiro EE, Soares FAA, Athayde
ML, Cruz IBM, unpublished data, 2011). Briefly, after
21 days of guaraná extraction the extract was centri-
fuged for 1000 g during 10 min and the supernatant was
isolated and lyophilized. The mainly xanthines and cate-
chins presented in guaraná extract were analyzed by
chromatography and from this analysis was found caf-
feine = 12.240 mg/g, theobromine = 6.733 mg/g, total
catechins = 4.336 mg/g, and condensed tannins = 22 mg/g.
The guaraná solution used in the study was prepared
based on Santa Maria et al [29] protocol. The extract
obtained and lyophilized was diluted in distillated water
prepared at a concentration of 200 mg/mL. The mix-
ture was infused for 7 min in boiling, and centrifuged
(600 g, 15 min) and filtered. Five guaraná concentra-
tions were tested here: 0.05, 0.1, 0.5, 1 and 5 μg/mL. In
TRAP assay were used different guaraná concentrations
(0.01-10 μg/mL).
LDL isolation to in vitro protocol tests
To perform in vitro LDL-oxidation assays in the
presence of guaraná, firstly the LDL was isolated from
fresh human plasma by discontinuous density-gradientultracentrifugation as described by Silva et al [30], with
few modifications. Briefly, plasma of three healthy normo-
lipidemic voluntary donors that did not ingest guaraná in
their habitual diet collected with EDTA (1 mg/mL) was
pooled and sucrose (final concentration, 0.5%) was added
to prevent LDL aggregation. Five milliliters of EDTA-
plasma adjusted to a density of 1.22 g/mL with solid KBr
(0.326 g/mL) was layered on the bottom of a centrifuge
tube. Then, 5 mL EDTA-containing sodium chloride solu-
tion (density 1.006 g/mL) was overlaid on the top of the
plasma. Ultracentrifugation was run at 350,000 g for 2 h
at 4°C, in a Himac CP80MX ultracentrifuge. LDL particles
were collected by the aspiration of the yellow/orange band
at the middle of the saline layer and dialyzed exhaustively
overnight at 4°C with 10 mM phosphate buffer (pH 7.4).
Protein concentration in LDL solution was determined by
Lowry’s method [31]. The purity of LDL preparation was
verified by agarose gel electrophoresis. Isolated LDL was
stored at −20°C for no longer than 2 weeks.
In vitro LDL oxidation analysis
Conjugated dienes and TBARS formation
LDL samples (50 μg protein/mL) were pre-incubated at
37°C in a medium containing 10 mM phosphate buffer
(pH 7.4) and different guaraná concentrations (0.05 –
5 μg/mL). After 5 minutes, the oxidation was initiated
by the addition of CuSO4 (5 μM, final concentration).
The oxidation was monitored by measuring the increase
in absorbance at 234 nm due to conjugated diene (CD)
formation as previously described [32]. Aliquots were
also removed at different time points for evaluating thio-
barbituric acid reactive substances (TBARS) production
as previously described [33].
Measurement of LDL- Tryptophan fluorescence
The fluorescence spectra of native LDL display a single
band centered at approximately 332 nm, which is assigned
to the tryptophan (Trp) residues in apolipoprotein B-100
(apoB-100) [34]. Loss of Trp fluorescence is a marker for
oxidations at the protein core of LDL [34]. Trp fluorescence
was measured in a solution of LDL (50 μg protein/mL) in
PBS (10 mM) pH 7.4 at 37°C, using a Shimatzo espectro-
fluorometer (excitation at 282 nm and emission at 331 nm)
[34]. The kinetics of LDL oxidation was followed by mea-
suring the decrease of Trp-fluorescence, corresponding to
the decomposition of this amino acid, after the addition of
CuSO4 (5 μM, final concentration), in absence or presence
of guaraná (0.05 – 5 μg/mL). The cuvettes had to be
removed from the excitation light between the single mea-
surements to avoid photooxidation of the Trp residues;
fluorescence was measured every 20 min. Data are shown
as the percent decrease of Trp fluorescence in each sample.
The time required for reaching half Trp fluorescence (t1/2)
was calculated.
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Venous blood was drawn from nonfasted healthy normoli-
pidemic voluntary donors into tubes containing no anti-
coagulant and centrifuged at 1000 g for 15 min. Serum
diluted 100-fold was incubated at 37°C in a medium con-
taining 10 mM phosphate buffer (pH 7.4) and different gua-
raná concentrations (0.05 – 5 μg/mL). The oxidation was
initiated by the addition of CuSO4 (30 μM) and CD forma-
tion was monitored at 245 nm as previously described [28].
Determination of lag phase and maximum oxidation rate
In the studies of CD formation, there are several para-
meters which can be obtained from diene vs. time profiles.
The value of the lag phase is commonly determined graph-
ically by the intercept of the tangents to the slow and fast
increase of the diene absorption. Another parameter is the
maximum oxidation rate, given by the peak of the first de-
rivative, i.e. change of A234 as a function of time [32].
Total radical-trapping antioxidant potential (TRAP)
TRAP was determined by measuring the chemilumines-
cence intensity of luminol induced by [2,20-azo-bis(2-
amidinopropane)-dihydrochloride] (AAPH) thermolysis
in a luminometer BioTek Synergy 2 [15]. The reaction
mixture contained AAPH (10 mM) and luminol (35 μM)
dissolved in 0.1 M glycine buffer (pH 8.6). Incubation of
this mixture generates an almost constant light intensity
at room temperature after stabilization. Guaraná was
added in different concentrations to determine the TRAP
activity. At this point, the luminescence intensity is prac-
tically abolished. In the course of time, with the loss of
antioxidant capacity of guaraná, the luminescence inten-
sity returns to the initial values. The area under curve
(AUC) was evaluated for each guaraná concentration and
compared to vehicle AUC [15].
Statistical analysis
Statistical analysis was performed using the SPSS statis-
tical package, version 17.0 (SPSS, Inc., IL). Data are
expressed as means ± SD. Comparison between charac-
teristics baselines and serum oxidation of GI and NG
elderly subjects was performed by Student t-test. Multi-
variate logistic regression (Backward Wald method) and
Pearson correlation tests were performed to observe pos-
sible intervenient factors. In vitro LDL-oxidation assays
were statistically analyzed using a one-way analysis of vari-
ance (ANOVA), followed by Student-Newman-Keuls test
when appropriate. In addition, linear regression was per-
formed to identify a possible dose dependent effect. Values
of p < 0.05 were considered significant.
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